1 study found for:    12218423 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation
Conditions: Conduct Disorder;   Oppositional Defiant Disorder;   Disruptive Behavior Disorder
Intervention: Drug: Risperidone oral solution

Indicates status has not been verified in more than two years